These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15750687)

  • 21. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are bisphosphonates useful in the management of corticosteroid induced osteoporosis in transplant patients?
    Arlen DJ; Adachi JD
    J Nephrol; 1999; 12(1):5-8. PubMed ID: 10202996
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
    Hasegawa M; Nisikawa M; Nomura S; Takubo T; Suehiro A; Saigo K; Hayashi K; Tamaki S; Mizutani M; Uemura Y; Kurata Y;
    Rinsho Ketsueki; 2005 Feb; 46(2):121-6. PubMed ID: 16447705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
    Masaki H; Miki T
    Clin Calcium; 2006 Nov; 16(11):1823-32. PubMed ID: 17079849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bisphosphonate inhibits glucocorticoid-induced osteoporosis].
    Ziegler R
    Med Monatsschr Pharm; 2006 Jan; 29(1):36. PubMed ID: 16463552
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and management of glucocorticoid-induced osteoporosis.
    Lane NE; Mroczkowski PJ; Hochberg MC
    Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788
    [No Abstract]   [Full Text] [Related]  

  • 31. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis.
    Doga M; Bonadonna S; Burattin A; Carpinteri R; Manelli F; Giustina A
    Front Horm Res; 2002; 30():150-64. PubMed ID: 11892263
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P; Laursen LC; Schwarz P; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):898-900. PubMed ID: 15789844
    [No Abstract]   [Full Text] [Related]  

  • 33. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
    Voskaridou E; Christoulas D; Antoniadou L; Terpos E
    Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glucocorticoid-induced osteoporosis and bone mineral densimetry].
    Tanaka I; Oshima H
    Clin Calcium; 2004 Dec; 14(12):77-82. PubMed ID: 15577178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M;
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2006 Jun; 25(2):72-8. PubMed ID: 16908396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
    Tanana I; Oshima H
    Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.